Public Company News & Press Release Distribution

SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Market

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the "Company"), a Nasdaq‑listed full‑stack AI infrastructure solutions provider, today announced that its subsidiary SuperX Microinference Pte Ltd ("Microinference") has signed an equipment and servic...

2026-08-28 21:44 7049

Fireblocks Sets Sights on Next Phase of Tokenization: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-08-28 21:19 4432

Fireblocks Sets Sights on Next Phase of Tokenization: NYSE Content Update

SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Market

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the "Company"), a Nasdaq‑listed full‑stack AI infrastructure solutions provider, today announced that its subsidiary SuperX Microinference Pte Ltd ("Microinference") has signed an equipment and servic...

2026-08-28 21:18 4460

Luxshare Precision Expects Net Profit to Rise 15%-25% in the First Nine Months of 2026

Growth outlook supported by continued execution across consumer electronics, AI data center infrastructure and automotive electronics DONGGUAN, China, Aug. 28, 2026 /PRNewswire/ -- Luxshare Precision Industry Co., Ltd. ("Luxshare Precision" or the "Company") (SZSE: 002475; HKEX: 02475), a global...

2026-08-28 21:00 4594

KLN Delivers Sustained Growth in Revenue and Core Net Profit

HONG KONG, Aug. 28, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN' or together with its subsidiaries, the 'Group'; Stock Code 0636.HK) today announced the Group's interim results for the six months ended 30 June 2026. Group's Financial Highlights and Dividend * Revenue grew by 10% yea...

2026-08-28 20:52 3549

Leifras Celebrates 25th Anniversary, Setting Vision for Becoming Global Infrastructure Through "Sports and Social"

Operating Across All 47 Prefectures in Japan, Ranking No. 1 in School Club Activity Support (According to Tokyo Shoko Research, as of December 2025) with Over 70,000 Sports School Members. Following Its Nasdaq Listing, Leifras Sets Vision for the Next 25 Years to Establish Sustainable Education, ...

2026-08-28 20:30 4616

Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers

TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug. 28, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWSE: 6838), today announced the submission of a Clinical Trial Application (CTA) to E...

2026-08-28 20:03 2491

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the ...

2026-08-28 19:30 3464

Tigermed Announces 2026 Interim Results

HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its 2026 interim results (the "Reporting Period"). ...

2026-08-28 17:56 4052

Unisound 2026 Interim Results: Revenue Up 38.7% YoY, Token Business Surges 760%, Large-Model Commercialization Accelerates Across the Board

HONG KONG, Aug. 28, 2026 /PRNewswire/ -- On August 28, Unisound (09678.HK) announced its interim results for the six months ended June 30, 2026. The results show that the company generated revenue of RMB 562 million in the first half of 2026, up 38.7% year over year, with commercialization accel...

2026-08-28 16:55 3604

Unisound 2026 Interim Results: Revenue Up 38.7% YoY, Token Business Surges 760%, Large-Model Commercialization Accelerates Across the Board

Zoomlion Reports 9.2% Revenue Growth in H1 2026, with International Revenue Up 12.5%

CHANGSHA, China, Aug. 28, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") reported revenue of RMB 27.14 billion (approx. US$4.04 billion) for the first half of 2026, up 9.17% year over year, with revenue increasing in both domestic and international market...

2026-08-28 16:43 4611

Zoomlion Reports 9.2% Revenue Growth in H1 2026, with International Revenue Up 12.5%

MINISO Group Announces 2026 June Quarter and Interim Unaudited Financial Results

Group Revenue Grew by 22.4% YoY in 26H1 MINISO Chinese Mainland Delivered 26.2% YoY Growth, the Highest First-half Growth Rate in Three Years, Powered by Mid-single Digit SSSG(1) MINISO North America Delivered 37.0% YoY Revenue Growth, with Mid-single Digit SSSG(1) Diluted Earnings Per ADS Grew by...

2026-08-28 16:34 3921

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

* Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and global commercialization * DUPAC, one of the DualityBio's four proprietary ADC technology platforms, comprises...

2026-08-28 12:20 2650

Beauty Farm 1H2026 Net Profit Surges 40%, Reinforcing Its Industry Leadership

1H2026 Performance Highlights: * Revenue reached RMB1.88 billion, up 29.0% year-on-year * Net profit reached RMB240 million, up 40.2% year-on-year * Gross profit margin reached 51.4%, up 2.1 percentage points year-on-year * Net cash flow generated from operating activities reached RMB550 mi...

2026-08-28 10:59 4248

Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company")announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales revenue, further advanced its global immuno-oncology (IO) 2.0 strategy, progressively built its IO2...

2026-08-28 10:44 6678

PhilWeb Elects Conglomerate Leader Lance Y. Gokongwei as Chairman to Accelerate AI Infrastructure and Transnational Ecosystem Expansion

MANILA, Philippines, Aug. 28, 2026 /PRNewswire/ -- PhilWeb Corporation (PSE: WEB) today announced the election of prominent business leader Lance Y. Gokongwei as Chairman of the Board of Directors. ...

2026-08-28 10:00 4180

PhilWeb Elects Conglomerate Leader Lance Y. Gokongwei as Chairman to Accelerate AI Infrastructure and Transnational Ecosystem Expansion

Visa Expands Support for its Clients and the Industry as Organisations Navigate New AI Era of Cybersecurity

Latest Visa Vulnerability Agentic Harness release moves AI-powered cyber risk management from discovery to validated remediation New services from Visa Consulting & Analytics help clients identify the vulnerabilities that matter most and act before bad actors do SINGAPORE, Aug. 28, 2026 /PRNewsw...

2026-08-28 09:01 26465

Luxshare Precision Reports 40.2% Revenue Growth in First Half 2026; Business Mix Supports Margin Expansion

Broad-based growth across consumer electronics, communications and data center, and automotive electronics, supported by targeted investment in AI infrastructure, intelligent vehicles and global delivery capacity DONGGUAN, China, Aug. 28, 2026 /PRNewswire/ -- Luxshare Precision Industry Co., Ltd...

2026-08-28 08:00 5081

Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion

INCHEON, South Korea, Aug. 27, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensional, long-term growth strategy across capacity, portfolio, and geogr...

2026-08-28 06:58 3980

Kazia Therapeutics Limited Announces Proposed Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that...

2026-08-28 05:14 4032